2026 ICD-10-CM Diagnosis Code T39.2X1SPoisoning by pyrazolone derivatives, accidental (unintentional), sequela

ICD-10-CM CodesS00–T88T36-T50T39

ICD-10-CM T39.2X1S
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T39.2X1S is a billable ICD-10-CM diagnosis code for poisoning by pyrazolone derivatives, accidental (unintentional), sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T39.2X1S
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by pyrazolone derivatives, accidental (unintentional), sequela
Short Description
Poisoning by pyrazolone derivatives, accidental, sequela
Parent Code
Poisoning by pyrazolone derivatives, accidental (unintentional)

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT39Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics
This CodeT39.2X1SPoisoning by pyrazolone derivatives, accidental (unintentional), sequela

Present on Admission (POA)Billing

T39.2X1S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Accidental azapropazone overdose
  • Accidental azapropazone poisoning
  • Accidental dichloralphenazone poisoning
  • Accidental oxyphenbutazone overdose
  • Accidental oxyphenbutazone poisoning
  • Accidental phenylbutazone overdose
  • Accidental poisoning by aminophenazone
  • Accidental poisoning by phenylbutazone
  • Accidental poisoning by pyrazole derivatives
  • Aminophenazone poisoning
  • Azapropazone overdose
  • Azapropazone poisoning
  • Dichloralphenazone poisoning
  • Oxyphenbutazone overdose
  • Oxyphenbutazone poisoning
  • Phenylbutazone overdose
  • Poisoning by phenylbutazone
  • Pyrazole derivative poisoning

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics (T39). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Aminopyrine

    a pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis. a breath test with 13c-labeled aminopyrine has been used as a non-invasive measure of cytochrome p-450 metabolic activity in liver function tests.
  • Aminopyrine N-Demethylase

    a pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis. a breath test with 13c-labeled aminopyrine has been used as a non-invasive measure of cytochrome p-450 metabolic activity in liver function tests.
  • Antipyrine

    an analgesic and antipyretic that has been given by mouth and as ear drops. antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (from martindale, the extra pharmacopoeia, 30th ed, p29)
  • Dipyrone

    a drug that has analgesic, anti-inflammatory, and antipyretic properties. it is the sodium sulfonate of aminopyrine.
  • Feprazone

    a pyrazole that has analgesic, anti-inflammatory, and antipyretic properties. it has been used in mild to moderate pain, fever, and inflammation associated with musculoskeletal and joint disorders. (from martindale, the extra pharmacopoeia, 30th ed, p15)
  • Oxyphenbutazone

    a non-steroidal anti-inflammatory drug. oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (from ama, drug evaluations annual, 1994, p2000) it had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (from martindale, the extra pharmacopoeia, 30th ed, p27)
  • Phenylbutazone

    a butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. it has been used in ankylosing spondylitis; rheumatoid arthritis; and reactive arthritis.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AmidopyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AminofenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AminophenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AminopyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AnalginT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AntipyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
AzapropazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
ButazolidinT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
ClofezoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
DiphenylbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
DipyroneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
FenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
FenylbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
FeprazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
HydroxyphenylbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
IndocinT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
IsopropylaminophenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
KebuzoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
KetazonT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Metamizole sodiumT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
MethampyroneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
MofebutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
MonophenylbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Myochrysin (e)T39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
NifenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
NoramidopyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Noramidopyrine::methanesulfonate sodiumT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
OxyphenbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
PhenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
PhenylT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::butazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::enediamineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::hydrazineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::hydrazine::antineoplasticT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::mercuric compoundsT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Phenyl::salicylateT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
PhenylbutazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
PropyphenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
PyramidonT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Pyrazole (derivatives)T39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Pyrazolone analgesic NECT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
RamifenazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
SulfamazoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
SulfamidopyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
SulpyrineT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
SuxibuzoneT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6
Tandearil, tanderilT39.2X1T39.2X2T39.2X3T39.2X4T39.2X5T39.2X6

Patient EducationClinical

Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T39.2X1S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.0 Late eff drug poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E929.2 Late eff acc poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T39.2X1SOverview

Is T39.2X1S a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by pyrazolone derivatives, accidental (unintentional), sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character S in T39.2X1S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the poisoning by pyrazolone derivatives, accidental (unintentional) itself has resolved, not the original event.

What MS-DRG does T39.2X1S group to?

When poisoning by pyrazolone derivatives, accidental (unintentional), sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.

Is T39.2X1S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for poisoning by pyrazolone derivatives, accidental (unintentional), sequela on inpatient claims.

What is the ICD-9 equivalent of T39.2X1S?

Under the General Equivalence Mappings, poisoning by pyrazolone derivatives, accidental (unintentional), sequela converts to ICD-9-CM 909.0 (late eff drug poisoning) and E929.2 (late eff acc poisoning). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.